| Pharmacokinetics and drug‐drug interactions of Isoniazid and Efavirenz in pregnant women living with HIV in high TB incidence settings: importance of genotyping K Gausi, L Wiesner, J Norman, CL Wallis, C Onyango‐Makumbi, ... Clinical Pharmacology & Therapeutics 109 (4), 1034-1044, 2021 | 29 | 2021 |
| A semimechanistic model of the bactericidal activity of high-dose isoniazid against multidrug-resistant tuberculosis: results from a randomized clinical trial K Gausi, EH Ignatius, X Sun, S Kim, L Moran, L Wiesner, ... American journal of respiratory and critical care medicine 204 (11), 1327-1335, 2021 | 25 | 2021 |
| Pharmacokinetics and target attainment of SQ109 in plasma and human-like tuberculosis lesions in rabbits O Egbelowo, JP Sarathy, K Gausi, MD Zimmerman, H Wang, GJ Wijnant, ... Antimicrobial agents and chemotherapy 65 (9), 10.1128/aac. 00024-21, 2021 | 15 | 2021 |
| Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women With HIV A Weinberg, L Aaron, G Montepiedra, TR Sterling, R Browning, ... Clinical infectious diseases 73 (9), e3555-e3562, 2021 | 14 | 2021 |
| Decreased dolutegravir and efavirenz concentrations with preserved virological suppression in patients with tuberculosis and human immunodeficiency virus receiving high-dose … C Sekaggya-Wiltshire, R Nabisere, J Musaazi, B Otaalo, F Aber, ... Clinical Infectious Diseases 76 (3), e910-e919, 2023 | 10 | 2023 |
| HIV infection has a profound effect on hematological factors but not on electrolyte profile of Malawian adults presenting with uncomplicated malaria and severe malaria AU Munyenyembe, K Gausi, TS Nyirenda, J Hiestand, J Mallewa, ... Journal of Blood Medicine, 153-162, 2018 | 8 | 2018 |
| Bedaquiline exposure in pregnancy and breastfeeding in women with rifampicin‐resistant tuberculosis R Court, K Gausi, B Mkhize, L Wiesner, C Waitt, H McIlleron, G Maartens, ... British journal of clinical pharmacology 88 (8), 3548-3558, 2022 | 7 | 2022 |
| Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis K Gausi, M Chirehwa, EH Ignatius, R Court, X Sun, L Moran, R Hafner, ... Journal of Antimicrobial Chemotherapy 77 (9), 2489-2499, 2022 | 6 | 2022 |
| The Effect of Frequent Exposure to P. falciparum, HIV-Infection and Other Co-Morbidities on Development of Severe Malaria in Malawian Adults AU Munyenyembe, K Gausi, J Hiestand, J Mallewa, W Mandala Infection and Drug Resistance, 63-68, 2020 | 4 | 2020 |
| Dolutegravir pharmacokinetics in Ugandan patients with TB and HIV receiving standard-versus high-dose rifampicin A Kengo, R Nabisere, K Gausi, J Musaazi, A Buzibye, D Omali, ... Antimicrobial Agents and Chemotherapy 67 (11), e00430-23, 2023 | 3 | 2023 |
| Pharmacokinetics and safety of twice-daily ritonavir-boosted atazanavir with rifampicin K Gausi, H Mugerwa, M Siccardi, MC Montanha, M Lamorde, L Wiesner, ... Clinical Infectious Diseases 78 (5), 1246-1255, 2024 | 2 | 2024 |
| Unexpectedly low drug exposures among Ugandan patients with TB and HIV receiving high-dose rifampicin A Kengo, K Gausi, R Nabisere, J Musaazi, A Buzibye, D Omali, ... Antimicrobial Agents and Chemotherapy 67 (11), e00431-23, 2023 | 2 | 2023 |
| High-Dose Isoniazid Lacks EARLY Bactericidal Activity Against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized, Phase 2 Clinical Trial K Gausi, EH Ignatius, V De Jager, C Upton, S Kim, A McKhann, L Moran, ... American Journal of Respiratory and Critical Care Medicine, 2024 | 1 | 2024 |
| Pharmacokinetics of isoniazid preventive therapy among HIV-infected pregnant women in high tuberculosis incidence settings K Gausi, L Weisner, J Norman, CL Wallis, C Onyango-Makumbi, ... 28th Annual Meeting of the Population Approach Group Europe (PAGE …, 2019 | 1 | 2019 |
| The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugs M Wijk, K Gausi, S Malatesta, SE Weber, R Court, B Myers, T Carney, ... Journal of Antimicrobial Chemotherapy, dkae206, 2024 | | 2024 |
| Population Pharmacokinetics of Antimalarial Naphthoquine in Combination with Artemisinin in Tanzanian Children and Adults: Dose Optimization AM Ali, K Gausi, SA Jongo, KR Kassim, C Mkindi, B Simon, AT Mtoro, ... Antimicrobial Agents and Chemotherapy 66 (5), e01696-21, 2022 | | 2022 |
| Pharmacometric modelling to inform and improve TB and HIV treatment: Focus on drug-drug interactions and neglected populations K Gausi | | 2022 |
| Methodological characterization of qt/qtc in children with severe malaria anaemia receiving arthemether-lumefantrine preceded by quinine K Gausi, KS Phiri, F ter Kuile, MB van Hensbroek, M Essan, D Terlouw, ... PAGE 2018, 2018 | | 2018 |
| Population Approach Group Europe Population Approach Group Europe SMS Ghadzi | | |
